Thursday, October 19, 2017

Gene therapy for blood cancer wins FDA approval

Customized "living drug" treatment for lymphoma is expected to cost $373,000 per patient

From: http://www.cbsnews.com/news/gene-therapy-lymphoma-blood-cancer-fda-approval/

No comments:

Post a Comment